DE60109299D1 - 2,2-disubstituierte 1,3-dioxolane als hustenmittel - Google Patents

2,2-disubstituierte 1,3-dioxolane als hustenmittel

Info

Publication number
DE60109299D1
DE60109299D1 DE60109299T DE60109299T DE60109299D1 DE 60109299 D1 DE60109299 D1 DE 60109299D1 DE 60109299 T DE60109299 T DE 60109299T DE 60109299 T DE60109299 T DE 60109299T DE 60109299 D1 DE60109299 D1 DE 60109299D1
Authority
DE
Germany
Prior art keywords
dioxolanes
disubstituted
human agent
piperazinyl
phenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60109299T
Other languages
English (en)
Other versions
DE60109299T2 (de
Inventor
Marcello Allegretti
Candida Cesta
Roberto Curti
Luca Nicolini
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dompe Farmaceutici SpA
Original Assignee
Dompe SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dompe SpA filed Critical Dompe SpA
Application granted granted Critical
Publication of DE60109299D1 publication Critical patent/DE60109299D1/de
Publication of DE60109299T2 publication Critical patent/DE60109299T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/28Radicals substituted by nitrogen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/14Antitussive agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Holo Graphy (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Hydrogenated Pyridines (AREA)
  • Compounds Of Alkaline-Earth Elements, Aluminum Or Rare-Earth Metals (AREA)
  • Glass Compositions (AREA)
  • Fats And Perfumes (AREA)
  • Liquid Crystal Substances (AREA)
  • Electrochromic Elements, Electrophoresis, Or Variable Reflection Or Absorption Elements (AREA)
  • Secondary Cells (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DE60109299T 2000-07-28 2001-07-18 2,2-disubstituierte 1,3-dioxolane als hustenmittel Expired - Lifetime DE60109299T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IT2000MI001735A IT1318651B1 (it) 2000-07-28 2000-07-28 Sintesi di (+-)1,3-diossolani e loro risoluzione ottica.
ITMI20001735 2000-07-28
PCT/EP2001/008305 WO2002010150A1 (en) 2000-07-28 2001-07-18 2,2-disubstituted 1,3-dioxolanes as antitussive agents

Publications (2)

Publication Number Publication Date
DE60109299D1 true DE60109299D1 (de) 2005-04-14
DE60109299T2 DE60109299T2 (de) 2005-07-21

Family

ID=11445592

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60109299T Expired - Lifetime DE60109299T2 (de) 2000-07-28 2001-07-18 2,2-disubstituierte 1,3-dioxolane als hustenmittel

Country Status (25)

Country Link
US (1) US6916926B2 (de)
EP (1) EP1307440B1 (de)
JP (1) JP5015403B2 (de)
KR (1) KR100788532B1 (de)
CN (1) CN1216053C (de)
AT (1) ATE290533T1 (de)
AU (1) AU2001281992A1 (de)
BR (1) BR0112802A (de)
CZ (1) CZ301039B6 (de)
DE (1) DE60109299T2 (de)
EE (1) EE05159B1 (de)
ES (1) ES2237589T3 (de)
HK (1) HK1058798A1 (de)
HU (1) HU229801B1 (de)
IL (2) IL153502A0 (de)
IT (1) IT1318651B1 (de)
MX (1) MXPA02012922A (de)
PL (1) PL206308B1 (de)
PT (1) PT1307440E (de)
RS (1) RS50862B (de)
RU (1) RU2269522C2 (de)
SI (1) SI21041B (de)
SK (1) SK286795B6 (de)
UA (1) UA73790C2 (de)
WO (1) WO2002010150A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1318650B1 (it) * 2000-07-28 2003-08-27 Dompe Spa 1,3-diossolani ad attivita' antitosse.

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4049660A (en) * 1971-06-18 1977-09-20 Delalande S.A. N-substituted derivatives of 4 (N-piperazinylmethyl) spiro dibenzocycloheptadi- (or tri-) ene-5, 2-dioxolane (1,3) their method of preparation and their application in therapeutics
IT1210639B (it) * 1981-02-25 1989-09-14 Menarini Sas Prodotto: 3(4-fenil1piperazinio-1-il)-1,2-propandiolo 3(teofillin-7-il)-1propansolfonato,utilizzabile in terapia,e relativo procedimento di fabbricazione
IT1203721B (it) * 1983-12-29 1989-02-23 Dompe Farmaceutici Spa Composti otticamente attivi ad attivita' antitosse e sedativa centrale,procedimento per la preparazione e composizioni che li contengono
SE449516B (sv) * 1984-10-16 1987-05-04 Skf Nova Ab Klemring med reglerbar halomkrets
IT1254452B (it) * 1992-02-14 1995-09-25 Dompe Farmaceutici Spa N-ossidi ed n,n'-diossidi di 3-(piperazin-1-il)-propan-1,2-dioli
IL111730A (en) * 1993-11-29 1998-12-06 Fujisawa Pharmaceutical Co Piperazine derivatives, processes for their preparation and pharmaceutical preparations containing them
IT1318650B1 (it) * 2000-07-28 2003-08-27 Dompe Spa 1,3-diossolani ad attivita' antitosse.

Also Published As

Publication number Publication date
ITMI20001735A1 (it) 2002-01-28
CN1444579A (zh) 2003-09-24
IT1318651B1 (it) 2003-08-27
SI21041A (sl) 2003-04-30
EE05159B1 (et) 2009-04-15
AU2001281992A1 (en) 2002-02-13
RU2269522C2 (ru) 2006-02-10
DE60109299T2 (de) 2005-07-21
ITMI20001735A0 (it) 2000-07-28
US6916926B2 (en) 2005-07-12
EP1307440A1 (de) 2003-05-07
SK902003A3 (en) 2003-09-11
SI21041B (en) 2005-08-31
EE200300035A (et) 2004-10-15
IL153502A (en) 2006-12-10
PT1307440E (pt) 2005-05-31
CZ2003269A3 (cs) 2003-06-18
CZ301039B6 (cs) 2009-10-21
KR100788532B1 (ko) 2007-12-24
US20030176446A1 (en) 2003-09-18
MXPA02012922A (es) 2003-10-06
JP2004505074A (ja) 2004-02-19
ES2237589T3 (es) 2005-08-01
HU229801B1 (en) 2014-07-28
ATE290533T1 (de) 2005-03-15
KR20030016424A (ko) 2003-02-26
YU3103A (sh) 2006-05-25
EP1307440B1 (de) 2005-03-09
SK286795B6 (sk) 2009-05-07
IL153502A0 (en) 2003-07-06
HK1058798A1 (en) 2004-06-04
WO2002010150A1 (en) 2002-02-07
PL206308B1 (pl) 2010-07-30
JP5015403B2 (ja) 2012-08-29
UA73790C2 (uk) 2005-09-15
RS50862B (sr) 2010-08-31
HUP0301473A2 (hu) 2003-08-28
PL361173A1 (en) 2004-09-20
BR0112802A (pt) 2003-07-01
CN1216053C (zh) 2005-08-24

Similar Documents

Publication Publication Date Title
CY1106871T1 (el) Νεα παραγωγα πυρρολιου σαν φαρμακευτικοι παραγοντες
EA200300459A1 (ru) Новые, применяемые в качестве медикаментов антихолинергические средства, а также способ их получения
EA200600925A1 (ru) Производные триазола в качестве антагонистов вазопрессина
DK0776324T3 (da) Endothelin-antagonister
CL2004001109A1 (es) Compuestos tien-3-il-sulfonilamino(tio) carbonil-triazolin(tio)onas sustituidas; procedimiento de obtencion; compuestos intermediarios; uso de los compuestos; y agentes herbicidas.
ATE202483T1 (de) Immuntolerante prothrombinkomplex-präparation
CY1105317T1 (el) Χρηση υποκατεστημενων ενωσεων 6-διμεθυλαμινομεθυλο-1-φαινυλο-κυκλοεξανιου για τη θepαπεια της ακρατειας ουρων
EA200400806A1 (ru) Способ получения эхинокандиновых соединений
DE60109299D1 (de) 2,2-disubstituierte 1,3-dioxolane als hustenmittel
BR0114380A (pt) Derivados-1-aminobutan-3-ol-substituìdos
DE60103164D1 (de) 1,3-dioxolanen mit hustenhemmender wirkung
DK1086071T3 (da) Hyperforinforbindelser, anvendelse heraf og formuleringer indeholdende disse
ATE258182T1 (de) Verbindungen selektif-inhibitoren der t gamma 9 delta 2 lymphocyten
IT1101704B (it) 6-inferiore alchil-7,8-diidrossi-1-fenil-2,3,4,5-tetraidro-1h-3-benzazepine
FI961793A0 (fi) Muistia parantavina aineina käyttökelpoiset 3-aryyli-4-alkyyli- ja 4,5-dialkyyli 4H-1,2,4-triatsolit
ES2037667T3 (es) Procedimiento para la obtencion de indolinas.
EA200200741A1 (ru) Способ получения эфиров арилиминометилкарбаминовой кислоты
ES2061738T3 (es) Procedimiento para la preparacion de 1,3-dioxolanos trisustituidos en 2,2,4 puros en cuanto a los enantiomeros.
EA200200090A1 (ru) Способ получения замещенных бензизотиазоловых соединений
AR027487A1 (es) Procedimiento para la preparacion de 3-fenil-4-[4-(metilsulfonil)feni]-2(5h)-furanona.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: DOMPE' PHA.R.MA S.P.A., L'AQUILA, IT